This site is intended for Healthcare professionals only.

Natco launches generic Hepatitis C drug Velpanat in Nepal


Natco launches generic Hepatitis C drug Velpanat in Nepal

New Delhi : Natco Pharma has launched a generic Hepatitis C treatment drug in Nepal under the brand name ‘Velpanat.’

The product is the first generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination sold by Gilead Sciences Inc under brand name Epclusa.



Source: PTI
0 comment(s) on Natco launches generic Hepatitis C drug Velpanat in Nepal

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted